Your browser doesn't support javascript.
loading
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.
Owonikoko, Taofeek K; Park, Keunchil; Govindan, Ramaswamy; Ready, Neal; Reck, Martin; Peters, Solange; Dakhil, Shaker R; Navarro, Alejandro; Rodríguez-Cid, Jerónimo; Schenker, Michael; Lee, Jong-Seok; Gutierrez, Vanesa; Percent, Ivor; Morgensztern, Daniel; Barrios, Carlos H; Greillier, Laurent; Baka, Sofia; Patel, Miten; Lin, Wen Hong; Selvaggi, Giovanni; Baudelet, Christine; Baden, Jonathan; Pandya, Dimple; Doshi, Parul; Kim, Hye Ryun.
Afiliación
  • Owonikoko TK; Winship Cancer Institute of Emory University, Atlanta, GA.
  • Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Govindan R; Alvin J Siteman Cancer Center at Washington University School of Medicine, St Louis, MO.
  • Ready N; Duke University Medical Center, Durham, NC.
  • Reck M; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany.
  • Peters S; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
  • Dakhil SR; Cancer Center of Kansas, Wichita, KS.
  • Navarro A; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Rodríguez-Cid J; Centro Oncológico, Médica Sur-Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
  • Schenker M; Centrul de Oncologie Sf Nectarie, Craiova, Romania.
  • Lee JS; Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Gutierrez V; Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Percent I; Florida Cancer Specialists, Punta Gorda, FL.
  • Morgensztern D; Alvin J Siteman Cancer Center at Washington University School of Medicine, St Louis, MO.
  • Barrios CH; Oncology Research Center, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.
  • Greillier L; Aix Marseille Univ, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, Marseille, France.
  • Baka S; Interbalkan European Medical Center, Thessaloniki, Greece.
  • Patel M; Cancer Specialists of North Florida, Jacksonville, FL.
  • Lin WH; Bristol Myers Squibb, Princeton, NJ.
  • Selvaggi G; Bristol Myers Squibb, Princeton, NJ.
  • Baudelet C; Bristol Myers Squibb, Princeton, NJ.
  • Baden J; Bristol Myers Squibb, Princeton, NJ.
  • Pandya D; Bristol Myers Squibb, Princeton, NJ.
  • Doshi P; Bristol Myers Squibb, Princeton, NJ.
  • Kim HR; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
J Clin Oncol ; 39(12): 1349-1359, 2021 04 20.
Article en En | MEDLINE | ID: mdl-33683919

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células Pequeñas / Ipilimumab / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Gabón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células Pequeñas / Ipilimumab / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Gabón